U.S. Organ Procurement Organizations are Strong, CMS Rule Threatens Future Success of Donation System
08 févr. 2024 12h18 HE
|
The Association of Organ Procurement Organizations
MCLEAN, Va., Feb. 08, 2024 (GLOBE NEWSWIRE) -- The Association of Organ Procurement Organizations (AOPO) is calling on the Centers for Medicare and Medicaid (CMS) to deliver a plan to stabilize the...
Europe Organ Transplant Diagnostics Market - Comprehensive Analysis and Forecast 2023-2033
30 janv. 2024 04h54 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Europe...
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
04 janv. 2024 16h40 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 déc. 2023 18h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
29 nov. 2023 16h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
With 6.00% CAGR, Organ Preservation Market Size Worth $348.02 Million by 2030 | Vantage Market Research
29 nov. 2023 09h19 HE
|
Vantage Market Research
WASHINGTON, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The Global Organ Preservation Market achieved a valuation of $218.36 Million in 2022 and is anticipated to exceed $348.02 Million by 2030, reflecting a...
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
09 nov. 2023 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
08 nov. 2023 16h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
02 nov. 2023 09h05 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
23 oct. 2023 07h00 HE
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer